Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Features

Features
What Is Eczema?

14 Aug 08

This feature 'What is Eczema?' is one of three features that focuses on the topic of skin conditions.
Pharmiweb Editor

What Is Psoriasis?

14 Aug 08

This feature 'What is Psoriasis?' is one of three features that focuses on the topic of skin conditions.
Pharmiweb Editor

What Is Acne?

13 Aug 08

This feature 'What is Acne?' is one of three features that focuses on the topic of skin conditions.
PharmiWeb Editor

Global Clinical Trials Business Report & Analysis 2008-2018

30 Jul 08

The global clinical trials business is worth an estimated $50bn in 2008, with a rate of growth of 10%. In recent years, the nature of clinical trials has changed considerably. An increased emphasis has been placed on cost-effectiveness of pharmaceutical R&D, as well as increased productivity to maintain the high output of recent years.
Visiongain Editor

Pain Management Conference 2008

11 Jul 08

The development of innovative therapeutics and complimentary technologies for the effective management of pain 7th – 8th October 2008, BSG Conference Centre, London, UK.
PharmiWeb Editor

What Is Arthritis?

09 Jul 08

Arthritis is not just a disease of older people – it can affect people of all ages, including children. It is not clear what causes arthritis and there is no cure at present. However, there is plenty you can do to manage yourcondition and lead a full and active life.
PharmiWeb Editor

New generation anti-TNF drug Cimzia (certolizumab pegol) may offer faster control of RA

17 Jun 08

Cimzia (certolizumab pegol) is the first and so far, only, PEGylated, Fc-Free, anti-tumour necrosis factor (TNF) alpha treatment in development for rheumatoid arthritis. Data presented at the Annual European Rheumatology Congress (EULAR) suggest that, in combination with methotrexate, Cimzia acts fast to significantly suppress disease activity, prevent structural damage to joints, preserve physical function and help patients continue working productively.
Olwen Glynn Owen - Pharmiweb Field reporter

Calling all Medical Journalists, Freelance Editors and Medical Experts

21 May 08

We have an enviable position of being visited by over 150,000 people each month looking for pharmaceutical news and jobs, and we need to satisfy their desire for content.
Mike Wood

Smoking - Why Quit?

21 May 08

It is estimated that one in two smokers will die from a smoking related disease, causing, on average, six to eight years of life lost per smoker. Smokers can also impact the health of those around them, for example their children, through passive smoking.
PharmiWeb editor

Blood Disorders Market Analysis & Forecasts Report to 2013

13 May 08

In 2007, blood diseases cost the US’s economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively. From oxygen delivery to immunological defence to clotting, blood has vital physiological functions, and clear, expensive treatments.
Editor

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.